The Shotlee Journal
Browse Shotlee articles about Ozempic.
Showing 9 / 1088 Ozempic articles
In Manhattan medspas and Bushwick fridges, peptides are fueling a quest for the perfect body—from GLP-1 pens vanquishing appetite to experimental vials promising telomere extension. But as biohackers chase the peptide Übermensch, what hidden costs lurk in this shift from treating illness to perfecting the self? Discover the cultural frenzy, market divides, and societal stakes.
A US dentist is raising alarms about 'Ozempic teeth,' a term for rapid tooth decay and gum issues in GLP-1 users. Dr. Gerry Curatola links it to slowed gastric emptying, bile flow, dry mouth, and vitamin deficiencies. While the drugs aid weight loss, awareness and simple prevention steps are key to avoiding dental pitfalls.
Weight-loss injections like GLP-1 medications are booming, but concerns about nutrient deficiencies are rising too. A review highlights risks for vitamins A, C, D, E, K and key minerals, sparking 'GLP-1 support' supplements. Expert Jordan Beaumont questions if they're necessary or just hype.
Ozempic-style weight loss patches are gaining buzz online as an easy alternative to injections, but do they deliver? Two experts break down the hype, revealing herbal ingredients with weak human evidence, poor skin absorption, and unproven safety. Find out why these GLP-1 patches may not help you shed kilos effectively.
Patients on GLP-1 medications are reporting a puzzling flat affect—not depression, but a sense of 'what's the point?' toward life goals and social plans. One doctor noticed this in three patients within a week, prompting deeper research into GLP-1s' impact on dopamine and motivation. Could this be an emerging side effect?
Despite the buzz around GLP-1 medications like Wegovy and Zepbound, obesity rates in the U.S. are projected to hit nearly 50% by 2030, per a New England Journal of Medicine study. Severe obesity (BMI 40+) continues to rise, highlighting disparities in food access and demographics. UVA expert Dr. Cate Varney breaks down what this means for public health and patients.
Kelly Osbourne stunned fans with her ultra-thin look at the 2026 Grammy Awards, reigniting 'Ozempic face' rumors despite her firm denial of using the drug. After losing 85 pounds through cutting sugar and carbs following gestational diabetes, public skepticism grows amid her skeletal appearance. Discover the story behind the transformation and medical insights on rapid weight loss effects.
Bollywood veteran Farida Jalal couldn't resist a cheeky remark about producer Sajid Nadiadwala's impressive 27-inch waistline, fueling ongoing rumors that Ozempic fueled his dramatic body transformation. As his film O Romeo hits theaters, the chatter highlights growing celebrity interest in GLP-1 medications for weight loss. Explore the story and science behind it.
Emerging research is spotlighting a potential link between popular GLP-1 medications like Ozempic and Wegovy and hair loss conditions such as telogen effluvium and androgenetic alopecia. A study of nearly 550,000 patients found a significant association after 12 months of use, even after adjusting for key factors. While benefits for diabetes and weight loss remain strong, awareness and monitoring are crucial.
